ATP6V1B2-related disorders featuring Lennox-Gastaut-syndrome: A case-based overview
Greta Amore1, Elisa Calì2, Maria Spanò3
1Department of Neuromuscular Disorders, UCL Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom; Unit of Child Neurology and Psychiatry, Department of Human Pathology of the Adult and Developmental Age "Gaetano Barresi", University of Messina, Via C. Valeria 1, 98125 Messina, Italy.
A novel ATP6V1B2 gene variant was identified in a patient with global developmental delay and epileptic encephalopathy. This finding expands the known spectrum of ATP6V1B2-related disorders, including developmental epileptic encephalopathies.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- ATP6V1B2 encodes a lysosomal proton pump subunit involved in organelle acidification and cellular functions.
- ATP6V1B2 variants are linked to multisystemic disorders with variable neurological involvement.
- Limited case reports hinder understanding of genotype-phenotype correlations in ATP6V1B2-related disorders.
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Inborn Errors of Metabolism
Lysosomal Hydrolases
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
ATP Synthase: Structure


